Stocks on the Move: MetLife, Inc. (MET), KeyCorp (KEY), The Walt Disney Company (DIS)

MetLife, Inc. (MET) failed to extend gains with the stock declining -0.52% or $-0.28 to close the day at $53.65 on active trading volume of 7.51M shares, compared to its three month average trading volume of 5.86M. The New York New York 10166 based company has been outperforming the life insurance group over the past 52 weeks, with the stock gaining 41.65%, compared to the industry which has advanced 43.59% over the same period. With RSI of 51.97, the stock should still continue to rise and get closer to its one year target estimate of $59.86, making it a hold for now.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

KeyCorp (KEY) fell -0.58% during last trading as the stock lost $-0.11 to finish the day at $18.99 with about 7.24M shares changing hands, compared to its three month average trading volume of 12.85M. The $20.39B market cap company, which fluctuated between $18.85 and $19.11 during the day, currently situated 90.49% above its 52 week low of $10.15 and -1.15% away from its one year high of $19.21. The RSI of 61.8 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States. The company’s Key Community Bank segment offers deposit and investment products; personal finance services and loans, including residential mortgages, home equity, credit cards, and various installment loans for individuals; deposits, investment and credit products, and business advisory services to small businesses; and financial, estate and retirement planning, and asset management services to high-net-worth clients. This segment also provides commercial lending, cash management, equipment leasing, investment and employee benefit programs, succession planning, access to capital markets, derivatives, and foreign exchange services to mid-sized businesses. Its Key Corporate Bank segment offers a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans for middle market clients comprising consumer, energy, healthcare, industrial, public, real estate, and technology sectors. In addition, KeyCorp provides personal, securities lending, and custody services; access to mutual funds; treasury, investment banking, international banking, and investment management services; public retirement plans, and foundations and endowments plans; and financial services consisting of community development financing, securities underwriting, and brokerage, as well as merchant services. As of December 31, 2015, the company operated 966 retail banking branches and 1,257 automated teller machines in 12 states, as well as a telephone banking call center. KeyCorp was founded in 1849 and is headquartered in Cleveland, Ohio.

The Walt Disney Company (DIS) saw its value increase by 0.48% as the stock gained $0.53 to finish the day at a closing price of $110.71. The stock was lighter in trading and has fluctuated between $89.61-$111.99 per share for the past year. The shares, which traded within a range of $110.09 to $110.87 during the day, are up by 14.19% in the past three months and up by 15.17% over the past six months. It is currently trading 1.31% above its 20 day moving average and 3.52% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $115.71 a share over the next twelve months. The current relative strength index (RSI) reading is 63.92. The technical indicator lead us to believe there will be no major movement any time soon, hold.

The Walt Disney Company, together with its subsidiaries, operates as an entertainment company worldwide. The company’s Media Networks segment operates cable programming services, including the ESPN, Disney channels, and Freeform networks; broadcast businesses, which include the ABC TV Network and eight owned television stations; radio businesses consisting of the ESPN Radio Network; and the Radio Disney network. It also produces and sells original live-action and animated television programming to first-run syndication and other television markets, as well as subscription video on demand services and in home entertainment formats, such as DVD, Blu-Ray, and iTunes. Its Parks and Resorts segment owns and operates the Walt Disney World Resort in Florida and the Disneyland Resort in California. This segment also operates Disney Resort & Spa in Hawaii, Disney Vacation Club, Disney Cruise Line, and Adventures by Disney; and manages Disneyland Paris, Hong Kong Disneyland Resort, and Shanghai Disney Resort, as well as licenses its intellectual property to a third party for the operations of the Tokyo Disney Resort in Japan. The company’s Studio Entertainment segment produces and acquires live-action and animated motion pictures for distribution in the theatrical, home entertainment, and television markets primarily under the Walt Disney Pictures, Pixar, Marvel, Lucasfilm, and Touchstone banners. This segment also produces stage plays and musical recordings; licenses and produces live entertainment events; and provides visual and audio effects, and other post-production services. Its Consumer Products & Interactive Media segment licenses its trade names, characters, and visual and literary properties; develops and publishes games for mobile platforms; and sells its products through The Disney Store, DisneyStore.com, and MarvelStore.com, as well as directly to retailers. The company was founded in 1923 and is based in Burbank, California.

 

Three Movers to Watch for: MetLife, Inc. (MET), Mylan N.V. (MYL), Alexion Pharmaceuticals, Inc. (ALXN)

MetLife, Inc. (MET) grew with the stock adding 0.71% or $0.38 to close at $53.88 on light trading volume of 4.93M compared its three months average trading volume of 6M. The New York New York 10166 based company operating under the Life Insurance industry has been trending up for the last 52 weeks, with the shares price now 46.67% up for the period and up by 0.72% so far this year. With price target of $59.86 and a 52.77% rebound from 52-week low, MetLife, Inc. has plenty of upside potential, making it a hold with a view buy.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Mylan N.V. (MYL) gained $0.97 to close the day at a new closing price of $40.75, a 2.44% increase in value from its previous closing price that moved the stock 21.28% above its 52 week low of $33.6. A total of 5.5M shares exchanged hands during the day compared with its three month average trading volume of 5.03M. The stock, which fluctuated between $39.56 and $40.91 during the day, currently situated -19.15% below its 52 week high. The stock is up by 10.94% in the past one month and up by 7.43% over the past three months. With a one year target estimate of $49.84 and RSI of 69.18, the stock still has upside potential, making it a hold for now.

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream, or ointment forms, as well as active pharmaceutical ingredients (APIs). It is also involved in the development of APIs with non-infringing processes for internal use and to partner with manufacturers; and manufacture and sale of injectable products in antineoplastics, anti-infectives, anesthesia/pain management, and cardiovascular therapeutic areas. In addition, the company produces finished dosage form and oral solid dose products; and offers antiretroviral therapies to third parties. Further, it manufactures and sells branded specialty injectable and nebulized products comprising EpiPen Auto-Injector to treat severe allergic reactions; Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients; and ULTIVA, an analgesic agent used during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. It sells generic pharmaceutical products to proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies; and specialty pharmaceuticals to pharmaceutical wholesalers and distributors, pharmacies, and healthcare institutions. Mylan N.V. has a collaboration agreement with Momenta Pharmaceuticals, Inc. to develop, manufacture, and commercialize Momenta Pharmaceuticals, Inc.’s biosimilar candidates. The company was formerly known as New Moon B.V. Mylan N.V. was founded in 1961 and is based in Hertfordshire, the United Kingdom.

Alexion Pharmaceuticals, Inc. (ALXN) shares were up in last trading by 1.35% to $129.5. It experienced higher than average volume on day. The stock increased in value by almost 1.39% over the past week and fell -5.43% in the past month. It is currently trading 1.49% above its 50 day moving average and 0.36% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -20.06% decrease in value from its one year high of $162. The RSI indicator value of 53.53, lead us to believe that it is a hold for now.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia (HPP); and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company also conducts Phase IV clinical trials on Soliris for the treatment of PNH registry; Phase III clinical trials for the treatment of myasthenia gravis, neuromyelitis optica spectrum disorder, and delayed kidney transplant graft function; and Phase II clinical trials for antibody mediated rejection in presensitized renal transplant patients. It develops cPMP (ALXN 1101) that is in Phase II/III trial for treating metabolic disorders; and ALXN 1007, a novel humanized antibody in Phase II clinical trial for the treatment of anti-phospholipid syndrome and graft versus host disease. The company serves distributors, pharmacies, hospitals, hospital buying groups, and other health care providers, as well as governments and government agencies in the United States, Europe, the Asia Pacific, and internationally. Alexion Pharmaceuticals, Inc. has agreements with X-Chem Pharmaceuticals (X-Chem) to identify novel drug candidates from X-Chem’s proprietary drug discovery engine; Moderna Therapeutics, Inc. (Moderna) that provides the option to purchase drug products for clinical development commercialization of Moderna’s messenger RNA therapeutics to treat rare diseases; and Ensemble Therapeutics Corporation for the identification, development, and commercialization of therapeutic candidates based on specific drug targets. The company was founded in 1992 and is headquartered in New Haven, Connecticut.

 

Stocks on Trader’s Radar: MetLife, Inc. (MET), Boston Scientific Corporation (BSX), Reynolds American Inc. (RAI)

MetLife, Inc. (MET) continued its upward trend with the stock climbing 0.63% or $0.33 to close the day at $52.91 on light trading volume of 4.98M shares, compared to its three month average trading volume of 6.4M. The New York New York 10166 based company has been outperforming the life insurance group over the past 52 weeks, with the stock gaining 55.53%, compared to the industry which has advanced 55.42% over the same period. With RSI of 45.34, the stock should still continue to rise and get closer to its one year target estimate of $59.86, making it a hold for now.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Boston Scientific Corporation (BSX) fell -0.55% during last trading as the stock lost $-0.14 to finish the day at $25.2 with about 4.95M shares changing hands, compared to its three month average trading volume of 8.33M. The $34.5B market cap company, which fluctuated between $25.2 and $25.43 during the day, currently situated 53.66% above its 52 week low of $16.62 and -0.98% away from its one year high of $25.45. The RSI of 76.47 indicates the stock is overbought at the current levels, sell for now.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Reynolds American Inc. (RAI) saw its value increase by 0.05% as the stock gained $0.03 to finish the day at a closing price of $60.57. The stock was lighter in trading and has fluctuated between $43.38-$60.91 per share for the past year. The shares, which traded within a range of $60.4 to $60.67 during the day, are up by 12.01% in the past three months and up by 23.02% over the past six months. It is currently trading 2.18% above its 20 day moving average and 6.38% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $57.01 a share over the next twelve months. The current relative strength index (RSI) reading is 77.18. The technical indicator do not lead us to believe the stock will see more gains any time soon.

Reynolds American Inc., through its subsidiaries, manufactures, and sells cigarettes and other tobacco products in the United States. It operates through RJR Tobacco, Santa Fe, and American Snuff segments. The RJR Tobacco segment offers cigarettes under the NEWPORT, CAMEL, PALL MALL, DORAL, MISTY, and CAPRI brands; and CAMEL Snus, a smoke-free tobacco product, as well as manages various licensed brands, including DUNHILL and STATE EXPRESS 555. The Santa Fe segment manufactures and markets cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand. The American Snuff segment provides smokeless tobacco products, such as moist snuff under GRIZZLY and KODIAK brand names. The company also manufactures and markets digital vapor cigarettes under the VUSE brand name; and markets nicotine replacement therapy products under the ZONNIC brand. It distributes its products primarily through direct wholesale deliveries from a local distribution center and public warehouses. Reynolds American Inc. was founded in 2004 and is headquartered in Winston-Salem, North Carolina.

 

Stocks in Focus: MetLife, Inc. (MET), Newmont Mining Corporation (NEM), Ally Financial Inc. (ALLY)

MetLife, Inc. (MET) had a light trading with around 6.3M shares changing hands compared to its three month average trading volume of 6.58M. The stock traded between $51.09 and $51.64 before closing at the price of $51.39 with -0.56% change on the day. The New York New York 10166 based company is currently trading 51.97% above its 52 week low of $35 and -10.88% below its 52 week high of $58.09. Both the RSI indicator and target price of 32.51 and $60.14 respectively, lead us to believe that it should be put on hold over the coming weeks.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Newmont Mining Corporation (NEM) managed to rebound with the stock climbing 1.42% or $0.53 to close the day at $37.85 on light trading volume of 6.18M shares, compared to its three month average trading volume of 8.14M. The Greenwood Village Colorado 80111 based company has been outperforming the gold group over the past 52 weeks, with the stock gaining 56.35%, compared to the industry which has advanced 6.38% over the same period. With RSI of 63.48, the stock should still continue to rise and get closer to its one year target estimate of $39.88, making it a hold for now.

Newmont Mining Corporation, together with its subsidiaries, operates in the mining industry. The company primarily acquires, develops, explores for, and produces gold. It also explores for silver and copper properties. The company’s operations and/or assets are located in the United States, Australia, Peru, Indonesia, Ghana, and Suriname. As of December 31, 2015, it had proven and probable gold reserves of 73.7 million ounces and an aggregate land position of approximately 20,000 square miles. The company was founded in 1916 and is headquartered in Greenwood Village, Colorado.

Ally Financial Inc. (ALLY) shares were down in last trading by -1.1% to $22.55. It experienced higher than average volume on day. The stock increased in value by almost 4.4% over the past week and grew 14.18% in the past month. It is currently trading 12.89% above its 50 day moving average and 20.94% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -1.18% decrease in value from its one year high of $22.82. The RSI indicator value of 73.98, lead us to believe that it may reverse gains in the near term.

Ally Financial Inc., a diversified financial services company, provides a range of financial products and services primarily to automotive dealers and their retail customers in the United States. It offers dealer financial services, including a range of financial services and insurance products to automotive dealers and retail customers. The company also provides automotive finance services for dealers, such as new and used vehicle inventory financing; inventory insurance; term loans, including real estate and working capital loans; and vehicle remarketing services, as well as vehicle service contracts (VCSs) and guaranteed automobile protection (GAP) products. In addition, it offers retail automotive financing for new and used vehicles, and leasing for new vehicles; consumer finance protection and insurance products, such as VSCs, maintenance coverage, and GAP products; commercial insurance products; and senior secured commercial-lending products. Further, the company, through its subsidiary, Ally Bank provides savings and money market accounts, certificates of deposit, interest-bearing checking accounts, trust accounts, and individual retirement accounts; and online and mobile banking, electronic bill pay, remote deposit, and electronic funds transfer. It also engages in the management of held-for-investment mortgage loan portfolio that includes the execution of bulk purchases of jumbo and low-to-moderate income mortgage loans originated by third parties. The company was formerly known as GMAC Inc. and changed its name to Ally Financial Inc. in May 2010. Ally Financial Inc. was founded in 1919 and is based in Detroit, Michigan.

 

Stocks In Queue: Applied Materials, Inc. (AMAT), MetLife, Inc. (MET), Weyerhaeuser Co. (WY)

Applied Materials, Inc. (AMAT) fell -0.37% during last trading as the stock lost $-0.13 to finish the day at $35.18 with about 5.82M shares changing hands, compared to its three month average trading volume of 10.29M. The $38.1B market cap company, which fluctuated between $35.01 and $35.39 during the day, currently situated 131.62% above its 52 week low of $15.44 and -0.59% away from its one year high of $35.39. The RSI of 64.87 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, display, and related industries worldwide. It operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits. It offers products and technologies for transistor and interconnect fabrication, including epitaxy, ion implantation, oxidation and nitridation, rapid thermal processing, chemical vapor deposition, physical vapor deposition, chemical mechanical planarization, and electrochemical deposition; patterning, selective removal, and packaging products and systems that enable the transfer of patterns onto device structures; and metrology, inspection, and review systems for front- and back-end-of-line applications. The Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity, including spares, upgrades, services, remanufactured earlier generation equipment, and factory automation software for semiconductor, display, and other products. The Display and Adjacent Markets segment offers products for manufacturing liquid crystal displays, organic light-emitting diodes, and other display technologies for TVs, personal computers, tablets, smart phones, and other consumer-oriented devices, as well as equipment for flexible substrates. The company serves manufacturers of semiconductor wafers and chips, liquid crystal and other displays, and other electronic devices. Applied Materials, Inc. was founded in 1967 and is headquartered in Santa Clara, California.

MetLife, Inc. (MET) gained $0.11 to close the day at a new closing price of $51.88, a 0.21% increase in value from its previous closing price that moved the stock 53.42% above its 52 week low of $35. A total of 5.82M shares exchanged hands during the day compared with its three month average trading volume of 6.59M. The stock, which fluctuated between $51.22 and $52.19 during the day, currently situated -10.03% below its 52 week high. The stock is down by -2.91% in the past one month and up by 11.06% over the past three months. With a one year target estimate of $60.14 and RSI of 36.62, the stock still has upside potential, making it a hold for now.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Weyerhaeuser Co. (WY) had a active trading with around 5.8M shares changing hands compared to its three month average trading volume of 4.09M. The stock traded between $31.03 and $32.05 before closing at the price of $31.42 with -2.15% change on the day. The Federal Way Washington 98003 based company is currently trading 48.41% above its 52 week low of $22.06 and -5.59% below its 52 week high of $33.28. Both the RSI indicator and target price of 52.3 and $34.88 respectively, lead us to believe that it should be put on hold over the coming weeks.

Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Seattle, Washington.

 

Stocks Under Review: MetLife, Inc. (MET), Archer-Daniels-Midland Company (ADM), CVS Health Corporation (CVS)

MetLife, Inc. (MET) continued its downward trend with the stock declining -0.89% or $-0.49 to close the day at $54.41 on light trading volume of 5.14M shares, compared to its three month average trading volume of 6.36M. The New York New York 10166 based company has been outperforming the life insurance group over the past 52 weeks, with the stock gaining 27.36%, compared to the industry which has advanced 28.8% over the same period. With RSI of 48.18, the stock should still continue to rise and get closer to its one year target estimate of $60.36, making it a hold for now.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Archer-Daniels-Midland Company (ADM) grew with the stock adding 0.29% or $0.13 to close at $44.26 on active trading volume of 5.04M compared its three months average trading volume of 3.49M. The Chicago Illinois 60601 based company operating under the Farm Products industry has been trending up for the last 52 weeks, with the shares price now 28.76% up for the period and down by -3.04% so far this year. With price target of $45.08 and a 44.56% rebound from 52-week low, Archer-Daniels-Midland Company has plenty of upside potential, making it a hold with a view buy.

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. Its Agricultural Services segment offers agricultural commodities, such as oilseeds, corn, wheat, milo, oats, rice, and barley; and resells those commodities as food and feed ingredients, and raw materials for the agricultural processing industry. The segment is also involved in structured trade finance and the processing of wheat into wheat flour. Its Corn Processing segment offers ingredients used in the food and beverage industry, including sweeteners, starch, syrup, glucose, and dextrose; bio products; alcohol, amino acids, and other food and animal feed ingredients; and ethyl alcohol for industrial use as ethanol or as beverage grade. This segment also offers corn gluten feed and meal, and distillers’ grains; vegetable oil and protein meal; formula feeds, and animal health and nutrition products; and citric acids and glycols for food and industrial products, as well as operates a sugarcane ethanol plant. The company’s Oilseeds Processing segment processes soybeans and soft seeds into vegetable oils and protein meals. It offers ingredients for the food, feed, energy, and industrial products industries; crude vegetable and salad oils; partially refined oils; oilseed protein meals; peanuts, tree nuts, and peanut-derived ingredients; cottonseed flour for the pharmaceutical industry; cotton cellulose pulp for the chemical, paper, and filter markets; and agricultural commodity raw materials. Its Wild Flavors and Specialty Ingredients segment offers natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, natural health and nutrition products, edible beans, and other specialty food and feed ingredients. The company is also involved in futures commission and insurance activities. Archer-Daniels-Midland Company was founded in 1898 and is headquartered in Chicago, Illinois.

CVS Health Corporation (CVS) continued its upward trend with the stock climbing 0.17% or $0.13 to close the day at $78.81 on lower than average trading volume of 6.42M shares, compared to its three month average trading volume of 8.67M. The Woonsocket Rhode Island 02895 based company has been outperforming the health care plans companies by -4.9998% for last three months and its recent losses have trimmed gains to 0.48% YTD, versus the health care plans industry which is up 1.69% for the same period. The RSI of 44.68 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Traders Recap: CenturyLink, Inc. (CTL), The Mosaic Company (MOS), MetLife, Inc. (MET)

CenturyLink, Inc. (CTL) failed to extend gains with the stock declining -0.38% or $-0.1 to close the day at $25.96 on higher than average trading volume of 4.94M shares, compared to its three month average trading volume of 11.18M. The Monroe Louisiana 71203 based company has been outperforming the telecom services – domestic companies by -6.1874% for last three months and its recent losses have trimmed gains to 9.17% YTD, versus the telecom services – domestic industry which is down -1.8% for the same period. The RSI of 65.17 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CenturyLink, Inc. provides various communications services to residential, business, wholesale, and governmental customers in the United States. It operates through two segments, Business and Consumer. The company offers high-speed Internet services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; multi-protocol label switching, a data networking technology to support real-time voice and video; and private line services for the transmission of data between sites. It also provides Ethernet services, including point-to-point and multi-point equipment configurations that facilitate data transmissions across metropolitan areas and wide area networks (WAN); colocation services that enable its customers to install their own information technology (IT) equipment; and managed hosting services comprising cloud and traditional computing, application management, back-up, storage, and other services. In addition, the company offers video entertainment services and satellite digital television; Voice over Internet Protocol, a real-time, two-way voice communication service; and managed services that consist of network, hosting, cloud, and IT services. Further, it provides local calling, long-distance voice, integrated services digital network, WAN, and switched access services; and data integration, which includes the sale of telecommunications equipment and providing network management, installation, and maintenance of data equipment, and the building of proprietary fiber-optic broadband networks. Additionally, the company leases and subleases space in its office buildings, warehouses, and other properties. As of December 31, 2015, it served approximately 6 million high-speed Internet subscribers and 285 thousand television subscribers; and operated 59 data centers in North America, Europe, and Asia. CenturyLink, Inc. was founded in 1968 and is headquartered in Monroe, Louisiana.

The Mosaic Company (MOS) had a light trading with around 4.89M shares changing hands compared to its three month average trading volume of 5.11M. The stock traded between $31.12 and $31.99 before closing at the price of $31.42 with -1.32% change on the day. The Plymouth Minnesota 55441 based company is currently trading 48.6% above its 52 week low of $22.02 and -7.56% below its 52 week high of $33.99. Both the RSI indicator and target price of 55.75 and $27.26 respectively, lead us to believe that it should be put on hold over the coming weeks.

The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients primarily for the agricultural industry worldwide. The company operates through three segments: Phosphates, Potash, and International Distribution. It owns and operates mines, which produce concentrated phosphate crop nutrients, such as diammonium phosphate, monoammonium phosphate, and ammoniated phosphate products; and phosphate-based animal feed ingredients primarily under the Biofos and Nexfos brand names. The company also produces and sells potash for use in the manufacturing of mixed crop nutrients and animal feed ingredients, and for industrial use; and for use in the de-icing and as a water softener regenerant, as well as fluorosilicic acid for water fluoridation. In addition, it provides nitrogen-based crop nutrients and animal feed ingredients, and other ancillary services; and purchases and sells phosphates, potash, and nitrogen products. The company sells its products to wholesale distributors, retail chains, cooperatives, independent retailers, and national accounts. The Mosaic Company was founded in 2004 and is headquartered in Plymouth, Minnesota.

MetLife, Inc. (MET) traded within a range of $55.37 to $55.94 after opening the day at $55.77. The company has seen its stock increase in value by 3.19% so far this year. The stock was down close to -0.75% on light volume in last trading session and closed at $55.61 per share. After the recent fall, the stock is currently holding -4.27% below its 52 week high of $58.09 and 63.24% above its 12-month low of $35. The shares are up by over 19.6% in the last three months, and the RSI indicator value of 58.54 is neither bullish nor bearish, tempting investors to stay on the sidelines.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

 

Stocks Trend Analysis: Las Vegas Sands Corp. (LVS), MetLife, Inc. (MET), Discover Financial Services (DFS)

Las Vegas Sands Corp. (LVS) continued its upward trend with the stock climbing 1.23% or $0.69 to close the day at $56.65 on active trading volume of 5.63M shares, compared to its three month average trading volume of 4.69M. The Las Vegas Nevada 89109 based company has been outperforming the resorts & casinos group over the past 52 weeks, with the stock gaining 46.33%, compared to the industry which has advanced 30.35% over the same period. With RSI of 52.94, the stock should still continue to rise and get closer to its one year target estimate of $61.65, making it a hold for now.

Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States. It owns and operates The Venetian Macao Resort Hotel, Sands Cotai Central, the Four Seasons Hotel Macao, Cotai Strip, the Plaza Casino, and the Sands Macao in Macao, the People’s Republic of China; and iconic Marina Bay Sands in Singapore. The company also owns and operates The Venetian Resort Hotel Casino, The Palazzo Resort Hotel Casino, and Five-Diamond luxury resorts on the Las Vegas Strip; Sands Expo and Convention Center in Las Vegas, Nevada; and the Sands Casino Resort Bethlehem in Bethlehem, Pennsylvania. Its integrated resorts include accommodations, gaming, entertainment and retail, convention and exhibition facilities, celebrity chef restaurants, and other amenities. Las Vegas Sands Corp. was founded in 1988 and is based in Las Vegas, Nevada.

MetLife, Inc. (MET) grew with the stock adding 2.26% or $1.24 to close at $56.15 on light trading volume of 5.53M compared its three months average trading volume of 6.39M. The New York New York 10166 based company operating under the Life Insurance industry has been trending up for the last 52 weeks, with the shares price now 33.76% up for the period and up by 4.19% so far this year. With price target of $60.46 and a 64.82% rebound from 52-week low, MetLife, Inc. has plenty of upside potential, making it a hold with a view buy.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Discover Financial Services (DFS) failed to extend gains with the stock declining -0.96% or $-0.67 to close the day at $69.21 on higher than average trading volume of 5.48M shares, compared to its three month average trading volume of 2.73M. The Riverwoods Illinois 60015 based company has been outperforming the credit services companies by 23.2828% for last three months and its recent gains have offset losses to -4% YTD, versus the credit services industry which is up 4.35% for the same period. The RSI of 40.74 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Discover Financial Services operates as a direct banking and payment services company in the United States. It operates in two segments, Direct Banking and Payment Services. The Direct Banking segment offers Discover-branded credit cards to individuals; and other consumer products and services, including private student loans, personal loans, home equity loans, and other consumer lending, as well as deposit products, such as certificates of deposit, money market accounts, savings accounts, checking accounts, and individual retirement arrangement certificates of deposit. The Payment Services segment operates the Discover Network, which processes transactions for Discover-branded credit cards, and provides payment transaction processing and settlement services; and PULSE network, an electronic funds transfer network that provides financial institutions issuing debit cards on the PULSE network with access to automated teller machines and point-of-sale terminals. This segment also operates the Diners Club International, a payments network that issues Diners Club branded charge cards and provides card acceptance services. The company was incorporated in 1960 and is based in Riverwoods, Illinois.

 

Investor’s Watch List: Walgreens Boots Alliance, Inc. (WBA), Kimberly-Clark Corporation (KMB), MetLife, Inc. (MET)

Walgreens Boots Alliance, Inc. (WBA) had a light trading with around 4.21M shares changing hands compared to its three month average trading volume of 4.4M. The stock traded between $80.62 and $81.81 before closing at the price of $81.23 with -0.39% change on the day. The Deerfield Illinois 60015 based company is currently trading 15.72% above its 52 week low of $71.5 and -7.69% below its 52 week high of $88. Both the RSI indicator and target price of 33.69 and $94.42 respectively, lead us to believe that it should be put on hold over the coming weeks.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services; and manages in-store clinics. As of August 31, 2016, this segment operated 8,175 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, toiletry, and other consumer products through its pharmacy-led health and beauty stores, as well as through boots.com. It is also involved in optical practice and related contract manufacturing operations. This segment operated 4,673 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 636 optical practices. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in France, the United Kingdom, Germany, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Kimberly-Clark Corporation (KMB) continued its upward trend with the stock climbing 4.11% or $4.81 to close the day at $121.79 on active trading volume of 4.21M shares, compared to its three month average trading volume of 1.92M. The Irving Texas 75038 based company has been outperforming the personal products group over the past 52 weeks, with the stock gaining 2.22%, compared to the industry which has advanced 8.73% over the same period. With RSI of 75.88, the stock should still continue to rise and get closer to its one year target estimate of $121.75, making it a hold for now.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and professional products worldwide. The Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise, and other brands. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and Jackson Safety brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce. It also sells products for away-from-home use through distributors and directly to manufacturing, lodging, office building, food service, and public facilities. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

MetLife, Inc. (MET) shares were up in last trading by 1.5% to $54.91. It experienced lighter than average volume on day. The stock increased in value by almost 2.54% over the past week and grew 0.6% in the past month. It is currently trading 0.35% above its 50 day moving average and 19.52% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -5.47% decrease in value from its one year high of $58.09. The RSI indicator value of 54.82, lead us to believe that it is a hold for now.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

 

3 Notable Runners: Pepsico, Inc. (PEP), MetLife, Inc. (MET), Medtronic plc (MDT)

Pepsico, Inc. (PEP) continued its upward trend with the stock climbing 0.75% or $0.77 to close the day at $104.01 on higher than average trading volume of 4.56M shares, compared to its three month average trading volume of 4.38M. The Purchase New York 10577 based company has been underperforming the beverages – soft drinks companies by -1.0114% for last three months and its recent losses have pulled the stock down -0.59% YTD, versus the beverages – soft drinks industry which is up 0.03% for the same period. The RSI of 54.96 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

PepsiCo, Inc. operates as a food and beverage company worldwide. Its Frito-Lay North America segment offers Lay’s and Ruffles potato chips; Doritos, Tostitos and Santitas tortilla chips; and Cheetos cheese-flavored snacks, branded dips, and Fritos corn chips. The company’s Quaker Foods North America segment provides Quaker oatmeal, grits, rice cakes, natural granola, and oat squares; and Aunt Jemima mixes and syrups, Quaker Chewy granola bars, Cap’n Crunch cereal, Life cereal, and Rice-A-Roni side dishes. Its North America Beverages segment offers beverage concentrates, fountain syrups, and finished goods under the Pepsi, Gatorade, Mountain Dew, Diet Pepsi, Aquafina, Diet Mountain Dew, Tropicana Pure Premium, Sierra Mist, and Mug brands; and ready-to-drink tea and coffee, and juices. The company’s Latin America segment provides snack foods under the Doritos, Cheetos, Marias Gamesa, Ruffles, Emperador, Saladitas, Sabritas, Lay’s, Rosquinhas Mabel, and Tostitos brands; cereals and snacks under the Quaker brand; and beverage concentrates, fountain syrups, and finished goods under the Pepsi, 7UP, Gatorade, Mirinda, Diet 7UP, Manzanita Sol, and Diet Pepsi brands. Its Europe Sub-Saharan Africa segment offers snack foods under the Lay’s, Walkers, Doritos, Cheetos, and Ruffles brands; cereals and snacks under the Quaker brand; beverage concentrates, fountain syrups, and finished goods under the Pepsi, 7UP, Pepsi Max, Mirinda, Diet Pepsi, and Tropicana brands; ready-to-drink tea products; and dairy products under the Chudo, Agusha, and Domik v Derevne brands. The company’s Asia, Middle East and North Africa segment provides snack foods under the Lay’s, Kurkure, Chipsy, Doritos, Cheetos, and Crunchy brands; cereals and snacks under the Quaker brand; beverage concentrates, fountain syrups, and finished goods under the Pepsi, Mirinda, 7UP, Mountain Dew, Aquafina, and Tropicana brands; and tea products. The company was founded in 1898 and is headquartered in Purchase, New York.

MetLife, Inc. (MET) had a light trading with around 4.55M shares changing hands compared to its three month average trading volume of 6.46M. The stock traded between $53.86 and $54.7 before closing at the price of $54.1 with -0.42% change on the day. The New York New York 10166 based company is currently trading 58.8% above its 52 week low of $35 and -6.87% below its 52 week high of $58.09. Both the RSI indicator and target price of 48.12 and $60.46 respectively, lead us to believe that it should be put on hold over the coming weeks.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Medtronic plc (MDT) traded within a range of $74.36 to $75.14 after opening the day at $74.72. The company has seen its stock increase in value by 4.97% so far this year. The stock was down close to -0.29% on light volume in last trading session and closed at $74.77 per share. After the recent fall, the stock is currently holding -16.24% below its 52 week high of $89.27 and 7.82% above its 12-month low of $69.35. The shares are down by over -11.01% in the last three months, and the RSI indicator value of 50.78 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.